false
0001873324
00-0000000
0001873324
2024-03-11
2024-03-11
0001873324
PEPL:UnitseachconsistingofoneClassAordinaryshareDollar0.0001parvalueandonehalfofoneredeemableMember
2024-03-11
2024-03-11
0001873324
us-gaap:CommonClassAMember
2024-03-11
2024-03-11
0001873324
PEPL:WarrantseachwholewarrantexercisableforoneClassAordinarysharesMember
2024-03-11
2024-03-11
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C.
20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
March 11, 2024
PepperLime Health Acquisition Corporation
(Exact name of registrant as specified in its
charter)
Cayman Islands |
|
001-40915 |
|
N/A |
(State or other jurisdiction
of incorporation) |
|
(Commission File Number) |
|
(I.R.S. Employer
Identification No.) |
548 Market Street, Suite 97425 San Francisco, CA |
|
94104 |
(Address of principal executive offices) |
|
(Zip Code) |
(415)
263-9939
(Registrant’s telephone number, including
area code)
N/A
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:
Title
for each class |
|
Trading
Symbol(s) |
|
Name of each exchange
on
which registered |
Units,
each consisting of one Class A ordinary share, $0.0001 par value, and one-half of one redeemable warrant |
|
PEPLU |
|
The
Nasdaq Stock Market LLC |
|
|
|
|
|
Class
A ordinary shares |
|
PEPL |
|
The
Nasdaq Stock Market LLC |
|
|
|
|
|
Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 |
|
PEPLW |
|
The
Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company x
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued
Listing Rule or Standard; Transfer of Listing.
As previously reported in Current Reports on Form 8-K
filed on February 2, February 12, and February 26, 2024, PepperLime Health Acquisition Corporation (the “Company”)
was not able to consummate an initial business combination by January 19, 2024 and has deposited funds to the trust account to extend
the time it has to consummate an initial business combination till March 19, 2024 while it explored options other than liquidation,
including a sale by the Company’s sponsor of all or a portion of the Company’s ordinary shares and private warrants it holds
to a new sponsor (the “Sponsor Sale”). The Company will not be able to consummate either an initial business combination or
a Sponsor Sale before March 19, 2024, and pursuant to the Company’s Amended and Restated Memorandum and Articles of Association,
the Company’s Board of Directors (the “Board”) has determined to (i) cease all operations except for the
purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Company’s
public Class A ordinary shares, par value $0.0001 per share (“Class A Ordinary Shares”), at a per-share price,
payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the
trust account (which interest shall be less taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the
number of then outstanding publicly held Class A Ordinary Shares, which redemption will completely extinguish public shareholders’
rights as shareholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably
possible following such redemption, subject to the approval of the holders of the Company’s Class B ordinary shares and the
Board, liquidate and dissolve.
The Company expects that the last day of trading
of its Class A Ordinary Shares, Redeemable Warrants and units (collectively, the “Securities”) on the Nasdaq Stock
Market LLC (“Nasdaq”) will be March 21, 2024. The Company expects that Nasdaq will thereafter file with the U.S.
Securities and Exchange Commission (the “SEC”) a Form 25 Notification of Removal from Listing and/or Registration
(“Form 25”) to delist and deregister the Company’s Securities under Section 12(b) of the Securities
Exchange Act of 1934, as amended (the “Exchange Act”). As a result, the Securities will no longer be listed on Nasdaq.
The Company thereafter intends to file a Form 15 Certification and Notice of Termination of Registration with the SEC, requesting
that the Company’s reporting obligations under Sections 13 and 15(d) of the Exchange Act be terminated with respect to the
Securities.
Item 8.01 Other Events.
The information set forth above in Item 3.01 of this Current Report
on Form 8-K is incorporated by reference herein.
In order to provide for the disbursement of funds
from the Company’s trust account, the Company will instruct Continental Stock Transfer & Trust Company, as trustee, to
take all necessary actions to liquidate the assets held in the trust account. The proceeds thereof, less $100,000 of interest to pay dissolution
expenses and net of taxes payable, will be held in a trust operating account while awaiting disbursement to the public holders of the
Class A Ordinary Shares (the “Redemption Amount”). All other costs and expenses associated with implementing the
Company’s plan of dissolution will be funded from proceeds held outside of the trust account. The Company anticipates that (i) its
Class A Ordinary Shares, as well as its publicly traded units and warrants, will cease trading as of the close of business on March 21,
2024 and (ii) the Redemption Amount will be paid to public holders of the Class A Ordinary Shares on or about March 22,
2024, without any required action on their part, at which point such shares shall be redeemed and canceled and will only have the right
to receive the Redemption Amount. Following such redemption, the Class A Ordinary Shares will no longer be outstanding and the Company’s
warrants will expire in accordance with their terms upon the liquidation of the Company. Beneficial owners of the Class A Ordinary
Shares held in “street name,” will not need to take any action in order to receive their pro rata portion of the Redemption
Amount. Registered holders of the public Class A Ordinary Shares will need to present proof of their respective Class A Ordinary
Shares to the Company’s transfer agent, Continental Stock Transfer & Trust Company, to receive their pro rata portion of
the Redemption Amount.
Forward-Looking Statements
This Current Report on Form 8-K contains
forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of
the Securities Exchange Act of 1934, as amended, that involve risks, uncertainties, and assumptions that are difficult to predict. All
statements other than statements of historical fact contained in this Current Report on Form 8-K, including statements regarding
future events, our future financial performance, business strategy, and plans and objectives of management for future operations, are
forward-looking statements. The Company has attempted to identify forward-looking statements by terminology including “anticipates,”
“believes,” “can,” “continue,” “could,” “estimates,” “expects,”
“intends,” “may,” “plans,” “potential,” “predicts,” or “should,”
or the negative of these terms or other comparable terminology. The forward-looking statements made herein are based on the Company’s
current expectations and assumptions about future events and are based on currently available information as to the outcome and timing
of future events. Actual results could differ materially from those described or implied by such forward-looking statements as a result
of various important factors, including, without limitation, its limited operating history, competitive factors in the Company’s
and Force’s industry and market, and other general economic conditions. The forward-looking statements made herein are based on
the Company’s current expectations, assumptions, and projections, which could be incorrect. The forward-looking statements made
herein speak only as of the date of this Current Report on Form 8-K and the Company undertakes no obligation to update publicly
such forward-looking statements to reflect subsequent events or circumstances, except as otherwise required by law. The Company cautions
you that these forward-looking statements are subject to all of the risks and uncertainties, most of which are difficult to predict and
many of which are beyond the control of the Company. Additional information concerning these and other factors that may impact the operations
and projections discussed herein can be found in the Company’s periodic filings with the SEC, including its Annual Report on Form 10-K
for the fiscal year ended December 31, 2022, and its subsequent Quarterly Report on Form 10-Q. The Company’s SEC filings
are available publicly on the SEC’s website at http://www.sec.gov.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
SIGNATURE
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
PepperLime Health Acquisition Corporation |
|
|
|
Dated: March 11, 2024 |
By: |
/s/ Ramzi Haidamus |
|
|
Name: Ramzi Haidamus |
|
|
Title: Chief Executive Officer |
|
|
|
Exhibit 99.1
PepperLime Health Acquisition Corporation Announces
plan to Liquidate
SAN FRANCISCO, March 11, 2024 – PepperLime
Health Acquisition Corporation (the "Company”) today announced that it will not be able to consummate by March 19, 2024
either an initial business combination or a Sponsor Sale previously contemplated and pursuant to its Amended and Restated Memorandum and
Articles of Association, the Company intends to liquidate promptly.
It is currently expected that public shareholders
will receive approximately $10.93 per share from the trust account of the Company (i.e., after payment of taxes and up to $100,000 of
interest to pay dissolution expenses) on or about March 22, 2024. Beneficial owners of the Company’s ordinary shares held in
“street name” will not need to take any action in order to receive the redemption amount. The Company’s sponsor waived
its liquidation rights with respect to its outstanding ordinary shares issued prior to the Company’s initial public offering. There
will be no liquidating distributions with respect to the Company’s redeemable warrants.
The Company expects that the last day of trading
of the Company’s Class A ordinary shares, redeemable warrants and units (collectively, the “Securities”) on the
Nasdaq Stock Market LLC (“Nasdaq”) will be March 21, 2024.
About PepperLime Health Acquisition Corporation
PepperLime Health Acquisition Corporation is a
blank check company incorporated in the Cayman Islands whose business purpose is to effect a merger, share exchange, asset acquisition,
share purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities.
Forward-Looking Statements
This press release may include, and oral statements
made from time to time by representatives of the Company may include, “forward-looking statements” within the meaning of Section 27A
of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements regarding
possible business combinations and the financing thereof, and related matters, as well as all other statements other than statements of
historical fact included in this press release are forward-looking statements. When used in this press release, words such as “anticipate,”
“believe,” “continue,” “could,” “estimate,” “expect,” “intend,”
“may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,”
“should,” “would” and similar expressions, as they relate to us or our management team, identify forward-looking
statements. Such forward-looking statements are based on the beliefs of management, as well as assumptions made by, and information currently
available to, the Company’s management. Actual results could differ materially from those contemplated by the forward-looking statements
as a result of certain factors detailed in the Company’s filings with the SEC. All subsequent written or oral forward-looking statements
attributable to us or persons acting on our behalf are qualified in their entirety by this paragraph. Forward-looking statements are subject
to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of
the Company’s registration statement and prospectus for the Company’s initial public offering filed with the SEC. The Company
undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.
Contact
Eran Pilovsky
Chief Financial Officer
PepperLime Health Acquisition Corporation
eran@pepperlimehealth.com
v3.24.0.1
Cover
|
Mar. 11, 2024 |
Document Information [Line Items] |
|
Document Type |
8-K
|
Amendment Flag |
false
|
Document Period End Date |
Mar. 11, 2024
|
Entity File Number |
001-40915
|
Entity Registrant Name |
PepperLime Health Acquisition Corporation
|
Entity Central Index Key |
0001873324
|
Entity Tax Identification Number |
00-0000000
|
Entity Incorporation, State or Country Code |
E9
|
Entity Address, Address Line One |
548 Market Street
|
Entity Address, Address Line Two |
Suite 97425
|
Entity Address, City or Town |
San Francisco
|
Entity Address, State or Province |
CA
|
Entity Address, Postal Zip Code |
94104
|
City Area Code |
415
|
Local Phone Number |
263-9939
|
Written Communications |
false
|
Soliciting Material |
false
|
Pre-commencement Tender Offer |
false
|
Pre-commencement Issuer Tender Offer |
false
|
Entity Emerging Growth Company |
true
|
Elected Not To Use the Extended Transition Period |
false
|
Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-half of one redeemable warrant [Member] |
|
Document Information [Line Items] |
|
Title of 12(b) Security |
Units,
each consisting of one Class A ordinary share, $0.0001 par value, and one-half of one redeemable warrant
|
Trading Symbol |
PEPLU
|
Security Exchange Name |
NASDAQ
|
Common Class A [Member] |
|
Document Information [Line Items] |
|
Title of 12(b) Security |
Class
A ordinary shares
|
Trading Symbol |
PEPL
|
Security Exchange Name |
NASDAQ
|
Warrants each whole warrant exercisable for one Class A ordinary share [Member] |
|
Document Information [Line Items] |
|
Title of 12(b) Security |
Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
|
Trading Symbol |
PEPLW
|
Security Exchange Name |
NASDAQ
|
X |
- DefinitionBoolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
+ Details
Name: |
dei_AmendmentFlag |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionFor the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
+ Details
Name: |
dei_DocumentPeriodEndDate |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:dateItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
+ Details
Name: |
dei_DocumentType |
Namespace Prefix: |
dei_ |
Data Type: |
dei:submissionTypeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 1 such as Attn, Building Name, Street Name
+ References
+ Details
Name: |
dei_EntityAddressAddressLine1 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 2 such as Street or Suite number
+ References
+ Details
Name: |
dei_EntityAddressAddressLine2 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Definition
+ References
+ Details
Name: |
dei_EntityAddressCityOrTown |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCode for the postal or zip code
+ References
+ Details
Name: |
dei_EntityAddressPostalZipCode |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the state or province.
+ References
+ Details
Name: |
dei_EntityAddressStateOrProvince |
Namespace Prefix: |
dei_ |
Data Type: |
dei:stateOrProvinceItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityCentralIndexKey |
Namespace Prefix: |
dei_ |
Data Type: |
dei:centralIndexKeyItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIndicate if registrant meets the emerging growth company criteria.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityEmergingGrowthCompany |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCommission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
+ Details
Name: |
dei_EntityFileNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:fileNumberItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTwo-character EDGAR code representing the state or country of incorporation.
+ References
+ Details
Name: |
dei_EntityIncorporationStateCountryCode |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarStateCountryItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityRegistrantName |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityTaxIdentificationNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:employerIdItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionLocal phone number for entity.
+ References
+ Details
Name: |
dei_LocalPhoneNumber |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 13e -Subsection 4c
+ Details
Name: |
dei_PreCommencementIssuerTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 14d -Subsection 2b
+ Details
Name: |
dei_PreCommencementTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTitle of a 12(b) registered security.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b
+ Details
Name: |
dei_Security12bTitle |
Namespace Prefix: |
dei_ |
Data Type: |
dei:securityTitleItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the Exchange on which a security is registered.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection d1-1
+ Details
Name: |
dei_SecurityExchangeName |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarExchangeCodeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Section 14a -Number 240 -Subsection 12
+ Details
Name: |
dei_SolicitingMaterial |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTrading symbol of an instrument as listed on an exchange.
+ References
+ Details
Name: |
dei_TradingSymbol |
Namespace Prefix: |
dei_ |
Data Type: |
dei:tradingSymbolItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 -Section 425
+ Details
Name: |
dei_WrittenCommunications |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Details
Name: |
us-gaap_StatementClassOfStockAxis=PEPL_UnitseachconsistingofoneClassAordinaryshareDollar0.0001parvalueandonehalfofoneredeemableMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_StatementClassOfStockAxis=PEPL_WarrantseachwholewarrantexercisableforoneClassAordinarysharesMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
Grafico Azioni PepperLime Health Acquis... (NASDAQ:PEPLU)
Storico
Da Ago 2024 a Set 2024
Grafico Azioni PepperLime Health Acquis... (NASDAQ:PEPLU)
Storico
Da Set 2023 a Set 2024